Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern-A first case-series experience

J Med Virol. 2023 Jan;95(1):e28181. doi: 10.1002/jmv.28181. Epub 2022 Oct 20.

Lennart Hermanussen¹, Ilka Grewe¹, Hui Ting Tang², Dominik Nörz², Lukas C Bal¹, Susanne Pfefferle², Stefan Unger³, Christian Hoffmann⁴, Dirk Berzow⁵, Matin Kohsar^{1

6}, Martin Aepfelbacher², Ansgar W Lohse^{1

7}, Marylyn M Addo^{1

7

8}, Marc Lütgehetmann^{2

7}, Julian Schulze Zur Wiesch^{1

7}, Stefan Schmiedel¹

¹ Department of Internal Medicine, Gastroenterology and Hepatology, Sections of Infectious Diseases and Tropical Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
³ Institute for interdisciplinary medicine (ifi), Hamburg, Germany.
⁴ ICH Hamburg-Stendal, Hamburg, Germany.
⁵ Praxis for Infectiology, Hamburg, Germany.
⁶ Department of Tropical Medicine Berhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
⁷ German Center for Infection Research, Hamburg-Lubeck-Borstel-Riems, Hamburg, Germany.
⁸ Institute for Infection research and Vaccine development (IIRVD), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

No abstract available

Publication types